LSN 2463359
CAS: 1401031-52-4
Rif. 3D-BGC03152
| 5mg | 338,00 € | ||
| 10mg | 436,00 € | ||
| 25mg | 728,00 € | ||
| 50mg | 1.044,00 € | ||
| 100mg | 1.670,00 € |
Informazioni sul prodotto
- 2-Pyridinecarboxamide, N-(1-methylethyl)-5-[2-(4-pyridinyl)ethynyl]-
- N-(1-Methylethyl)-5-[2-(4-pyridinyl)ethynyl]-2-pyridinecarboxamide
LSN 2463359 is a novel, potent, and selective allosteric modulator of the metabotropic glutamate receptor. It is currently in clinical development for the treatment of neurodevelopmental disorders such as attention deficit hyperactivity disorder (ADHD) and narcolepsy. LSN 2463359 has been shown to be safe and well tolerated in vivo studies in rats and mice. The drug improved ADHD-related symptoms in rodent models of ADHD. LSN 2463359 also reduced cataplexy episodes in narcoleptic patients who had been unresponsive to other treatments.
Proprietà chimiche
Richiesta tecnica su: 3D-BGC03152 LSN 2463359
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
